### ZNF385D-AS2 Gene Overview

**Gene Symbol**: ZNF385D-AS2

The ZNF385D-AS2 gene is classified as an antisense long non-coding RNA (lncRNA). The function of lncRNAs, including ZNF385D-AS2, is still an active area of research, but they are known to play critical roles in gene regulation, including transcriptional and post-transcriptional control.

### 1. Associated Genes

While the specific NCBI and UniProt summaries may not provide details on other genes directly linked or co-expressed with ZNF385D-AS2, it is common for lncRNAs to interact with various coding genes and signal pathways. 

Some common genes that may be associated with antisense RNA include:
- **ZNF385D**: As an associated gene due to the overlapping region or proximity on the genome, inducing speculation on regulatory roles.
- **Other members of the ZNF (Zinc Finger protein) family**: These are often linked due to similar regulatory functions in chromatin organization and gene expression.

Further specific studies and database searches (e.g., GeneCards, STRING, or BioGRID) would be beneficial to identify additional genes explicitly related to ZNF385D-AS2.

### 2. Aging and Age-Related Diseases

Current research specifically linking ZNF385D-AS2 to aging or age-related diseases may not be extensively documented. However, given the association of long non-coding RNAs in cellular aging, stress responses, and differentiation processes, there is a potential for ZNF385D-AS2 to play a role in:
- **Cellular Senescence**: LncRNAs have been implicated in the regulation of senescence pathways.
- **Age-Related Diseases**: Alterations in the expression of lncRNAs have been observed in conditions like cancer, neurodegeneration, and cardiovascular diseases, indicating a possible role in age-related pathologies.

Future investigations may clarify any direct involvement of ZNF385D-AS2 in these processes.

### 3. Drug Interactions

Currently, specific drugs or drug classes that directly target or interact with ZNF385D-AS2 are not extensively documented in available databases. Given that ZNF385D-AS2 is a long non-coding RNA, traditional drug interactions may not apply in the same way as they do to protein-coding genes. However, some studies suggest that alterations in the expression of lncRNAs can affect the efficacy of certain treatments for cancer and other diseases. 

It is essential to monitor ongoing research as this field is rapidly evolving.

### 4. Pathways and Biological Processes

ZNF385D-AS2 may be involved in several biological processes and pathways, as is typical for antisense lncRNAs. These can include:
- **Gene Regulation**: LncRNAs often play roles in chromatin remodeling and modulation of gene transcription, either by directly interacting with chromatin modifiers or through influencing transcription factor binding.
- **Response to Stress**: Antisense lncRNAs can be activated in response to cellular stress, influencing survival pathways.
- **Development and Differentiation**: There is some evidence that lncRNAs regulate processes pertinent to cellular differentiation.

Additionally, specific pathways like the **Wnt signaling pathway**, **PI3K-Akt signaling pathway**, or others might be influenced indirectly through the pathways regulated by associated genes.

### Conclusion

The ZNF385D-AS2 gene exemplifies the complex role of non-coding RNAs in cellular processes. As research continues, particularly in the fields of cancer biology, neurobiology, and aging, a more refined picture of how ZNF385D-AS2 contributes to health and disease will emerge. For precise applications or investigations, accessing the latest research articles and databases is critical.